Newsroom

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata launches OmniNode™, an off-the-shelf high-voltage power distribution solution that simplifies commercial EV architecture....

NEW YORK--(BUSINESS WIRE)--Forus, the AI network accelerating medicine, today announced $150 million in Series C financing at a $3 billion valuation, tripling its valuation just months after announcing its Series B and bringing total funding to more than $300 million. The round was led by Bain Capital Ventures, an investor in Forus since its seed round. Every existing institutional investor is reinvesting, including Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Vent...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 07.09.2026 FBTU.LN IE00BL0L0H60  500,002.00 USD  16,583,417.94   33.167  ...

ATLANTA--(BUSINESS WIRE)--DC BLOX, a leading provider of connected data center and fiber network solutions across the Southeastern United States, today announced the launch of the DC BLOX Community Commitment, a formal pledge outlining the company's responsibilities to the communities where it develops and operates digital infrastructure. The Community Commitment codifies ten foundational pillars, including power and grid enhancement, water conservation, sound management, air quality, responsib...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 07.09.2026 NXTG.LN IE00BWTNM743  170,002.00 USD   9,676,887.30   56.922  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 07.09.2026 FTCS. IE00BL0L0D23  225,002.00 USD   7,811,361.77   34.717  ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the European Epilepsy Congress....

SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today presented a quantitative imaging post hoc analysis from its Phase 2a trial evaluating its investigational therapy taladegib (ENV-101) in individuals with idiopathic pulmonary fibrosis (IPF). Results demonstrated significant improvement in lung volume, as well...

DALLAS--(BUSINESS WIRE)--Vital Capital Partners, a healthcare real estate investment manager, announced today the full subscription of a $9.67 million private placement offering, HPA Exchange – Vital Medical Dallas TX DST, through the independent broker-dealer and registered investment advisor network. Vital Capital Partners sponsored the offering through a joint venture. This marks the third medical Delaware statutory trust offering the firm has fully subscribed since entering the private wealt...

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode today announced a distribution agreement with Henry Schein, a leading provider of healthcare products and services, to expand the availability of its BioCode® MDx-3000 System and comprehensive molecular diagnostics menu. The BioCode® MDx-3000 is an automated, high-throughput multiplex molecular diagnostic platform designed to support high-complexity clinical laboratories. Its testing menu includes upper respiratory and gastrointestinal...